Welcome to AstraZeneca United States

We push the boundaries of science to deliver life-changing medicines

AZ&You Blog
 

Nina Parker on Breaking the Cycle of Asthma

From Diagnosis to Late-Stage: AstraZeneca’s Commitment to Patients with Chronic Kidney Disease

Advancing Health Equity through Community-Based Contributions – Announcing the ACT on Health Equity Community Solutions Challenge Recipients

From the Experts: Taking Control of Flu Season

Latest News from AstraZeneca US
 

IMFINZI® (durvalumab) plus tremelimumab demonstrated unprecedented survival in 1st-line unresectable liver cancer with 31% of patients alive at three years

IMFINZI® (durvalumab) plus chemotherapy reduced risk of death by 20% in 1st-line advanced biliary tract cancer

ENHERTU® granted Priority Review in the US for patients with HER2-positive metastatic breast cancer treated with a prior anti-HER2-based regimen

AstraZeneca aims to redefine liver, biliary tract and prostate cancer treatment with practice-changing IMFINZI® (durvalumab) and LYNPARZA® (olaparib) data at ASCO GI and GU

TEZSPIRE Now Available in the United States for the Treatment of Severe Asthma

EVUSHELD long-acting antibody combination retains neutralizing activity against Omicron variant in studies from Oxford and Washington Universities

TEZSPIRE (tezepelumab) approved in the US for severe asthma

Follow AstraZeneca on Twitter and Facebook

Pascal Soriot calls for global cooperation in the fight against COVID-19 and climate change

COVID-19 Information Hub

BioPharmaceuticals

We want to transform healthcare, change the lives of billions of people for the better and address some of the biggest healthcare challenges facing humankind. Our ambition is to stop the progress of these often degenerative, debilitating, and life-threatening conditions, achieve remission, and one day cure them.

Learn more

Oncology: Start with One

At AstraZeneca, we are leading a revolution in oncology to redefine cancer care for the millions of Americans living with cancer. It’s a lofty ambition. But we know that as with every great journey, the road always starts with one—one indication that can change the course of disease for a patient, one person living with cancer that benefits from our support services, one access barrier that we can help to overcome, one system to transform in partnership with the community—and then another, building from there until success is achieved. Click below to read more about this next chapter.

Learn more